We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-5.37%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$246M
AUM Growth
-$19.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$192M 77.88%
19,363,975
PLRX icon
2
Pliant Therapeutics
PLRX
$64.4M
$38.6M 15.69%
2,132,867
FULC icon
3
Fulcrum Therapeutics
FULC
$273M
$15.8M 6.43%
2,343,154

Similar funds

TRV GP IV's Q4 2023 Portfolio in Review

As of Q4 2023, TRV GP IV held 3 positions worth $246M, down 7.3% from $265M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. TRV GP IV opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's ten largest holdings make up 100% of its $246M portfolio in Q4 2023.
  • TRV GP IV opened 0 new positions and closed 0 in Q4 2023.
  • TRV GP IV's portfolio value fell 7.3% quarter-over-quarter to $246M.

Based on TRV GP IV's 13F filing for Q4 2023, filed 14 Feb 2024.